Tag: Prescription Drugs
Meta-Analyses Link Rosiglitazone to Increased Cardiovascular Risk
Authors call for sharing of individual patient data to strengthen meta-analyses focused on safety
Some Lifestyle Changes Suffer With Start of Meds to Cut CV Risk
Likelihood of becoming obese, physically inactive increased for initiators of antihypertensives, statins
Racial/Ethnic, Sex, Insurance Disparities ID’d in Acne Care
Non-Hispanic black patients more likely to be seen by dermatologist but receive fewer prescriptions
Bumetanide Promising for Reducing Autism Symptoms
Decrease in GABA/glutamate ratio in insular cortex tied to symptom improvement in bumetanide group
Costs of ART Regimens Increasing, Outpacing Inflation
Annual average wholesale price of initial ART regimens recommended for most persons with HIV >$36,000
More Naloxone Orders Filled When Pharmacists Can Dispense
2,328 percent increase in naloxone orders found in Ohio Medicaid population after policy implementation
Experimental Antiviral Drug to Be Tested Against New Coronavirus
Trial to be conducted in the central Chinese city of Wuhan, the epicenter of the outbreak
Early Treatment Tied to Less Disability With Pediatric-Onset MS
Less disability seen among those initiating disease-modifying therapy within two years of clinical onset
Hydromorphone-CR Exposure Ups Heart Infection Risk in PWID
Rates of infective endocarditis increased among PWID exposed to controlled-release hydromorphone
Opioid Prescribing Rates Down at State Level From 2010 to 2016
Among 11 states, daily dosage declined the least in Idaho and Maine, the most in Florida
